An International Observational Prospective Survey Assessing the Control of Atrial Fibrillation in Asia-Pacific: Results of the Record-AFAP Registry

A prospective 1-year observational survey was designed to assess the management and control of atrial fibrillation (AF) in eight countries within the Asia-Pacific region. Patients (N = 2,604) with recently diagnosed AF or a history of AF ≤1 year were included. Clinicians chose the treatment strategy...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Clinical Medicine Insights. Cardiology Ročník 2015; číslo 9; s. 77 - 83
Hlavní autoři: Amerena, John, Chen, Shih-Ann, Sriratanasathavorn, Charn, Cho, Jeong-Gwan, Dejia, Huang, Omar, Razali, Fat, Tse Hung, King, Anthony
Médium: Journal Article
Jazyk:angličtina
Vydáno: London, England Libertas Academica 01.01.2015
SAGE Publishing
SAGE Publications
Témata:
Original Research
Record-AFAP
sinus arrhythmia
atrial fibrillation
rate control
cardiac glycosides
rhythm control
ISSN:1179-5468, 1179-5468
On-line přístup:Získat plný text
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
Popis
Shrnutí:A prospective 1-year observational survey was designed to assess the management and control of atrial fibrillation (AF) in eight countries within the Asia-Pacific region. Patients (N = 2,604) with recently diagnosed AF or a history of AF ≤1 year were included. Clinicians chose the treatment strategy (rhythm or rate control) according to their standard practice and medical discretion. The primary endpoint was therapeutic success. At baseline, rhythm- and rate-control strategies were applied to 35.7% and 64.3% of patients, respectively. At 12 months, therapeutic success was 43.2% overall. Being assigned to rhythm-control strategy at baseline was associated with a higher therapeutic success (46.5% vs 41.4%; P = 0.0214) and a lower incidence of clinical outcomes (10.4% vs 17.1% P < 0.0001). Patients assigned to rate-control strategies at baseline had higher cardiovascular morbidities (history of heart failure or valvular heart disease). Cardiovascular outcomes may be less dependent on the choice of treatment strategy than cardiovascular comorbidities.
Bibliografie:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1179-5468
1179-5468
DOI:10.4137/CMC.S22022